Metabolic effects of large-volume liposuction for obese healthy women: a meta-analysis of fasting insulin levels.
Boriani F., Villani R., Morselli PG.
Meta-analysis on Type 2 Diabetes, published in Aesthetic Plast Surg (2014) — summary generated from the PubMed abstract.
This page is generated from the PubMed record. The Thai description is an automated summary of bibliographic fields and the abstract, not a full translation, and is not medical advice.
- Study type
- Meta-analysis
- Journal
- Aesthetic Plast Surg (2014)
- Country
- United States
- Reported sample size
- —
- PMID
- 25099498
- DOI
- 10.1007/s00266-014-0386-3
Abstract (original English)
Obesity is increasingly frequent in our society and is associated closely with metabolic disorders. As some studies have suggested, removal of fat tissue through liposuction and dermolipectomies may be of some benefit in the improvement of metabolic indices. This article aimed to review the published literature on this topic and to evaluate metabolic variations meta-analytically after liposuction, dermolipectomy, or both. Through a literature search with the PubMed/Medline database, 14 studies were identified. All articles were analyzed, and several metabolic variables were chosen in the attempt to meta-analyze the effect of adipose tissue removal through the various studies. All statistical calculations were performed with Review Manager (RevMan), version 5.0. Several cardiovascular and metabolic variables are described as prone to variations after body-contouring procedures when a significant amount of adipose tissue has been excised. Four of the studies included in the analysis reported improvements in all the parameters examined. Seven articles showed improvement in some variables and no improvement in others, whereas three studies showed no beneficial variation in any of the considered indicators after body-contouring procedures. Fasting plasma insulin was identified as the only variable for which a meta-analysis of five included studies was possible. The meta-analysis sho
What this study does not prove
- • This study does not prove SVF is an approved treatment or a replacement for standard care.
Evidence level
Relatively higher-quality human studies compared with other topics in this database, e.g. multiple RCTs or systematic reviews. This does not mean it is standard or approved care.
How we grade evidenceRelated research
- Level ASystematic Review
Systematic Review: Exosomes as Molecular Messengers in the Development of Obesity-Related Complications in Children.
Systematic Review on Type 2 Diabetes, published in Curr Issues Mol Biol (2025) — summary generated from the PubMed abstract.
- 2025
Curr Issues Mol Biol - Level AMeta-analysis
Type 2 Diabetes Mellitus Induced Paracrine Effects on Breast Cancer Metastasis Through Extracellular Vesicles Derived from Human Mesenchymal Stem Cells.
Meta-analysis on Type 2 Diabetes, published in Stem Cells Dev (2020) — summary generated from the PubMed abstract.
- 2020
Stem Cells Dev - Level ASystematic Review
Adipose-derived Mesenchymal Stem Cells in the Treatment of Obesity: A Systematic Review of Longitudinal Studies on Preclinical Evidence.
Systematic Review on Type 2 Diabetes, published in Curr Stem Cell Res Ther (2018) — summary generated from the PubMed abstract.
- 2018
Curr Stem Cell Res Ther - Level BClinical Trial
Safety and efficacy of autologous adipose tissue-derived stem cell transplantation in aging-related low-grade inflammation patients: a single-group, open-label, phase I clinical trial.
Clinical Trial on Type 2 Diabetes, Neuroinflammation, Immune Modulation, published in Trials (2024) — summary generated from the PubMed abstract.
- 2024
Trials - Level BRandomized Controlled Trial
Using adipose-derived mesenchymal stem cells to fight the metabolic complications of obesity: Where do we stand?
Randomized Controlled Trial on Type 2 Diabetes, Immune Modulation, published in Obes Rev (2022) — summary generated from the PubMed abstract.
- 2022
Obes Rev - Level BClinical Trial
The possible role of visceral fat in early pregnancy as a predictor of gestational diabetes mellitus by regulating adipose-derived exosomes miRNA-148 family: protocol for a nested case-control study in a cohort study.
Clinical Trial with a reported sample of 3000 on Type 2 Diabetes, published in BMC Pregnancy Childbirth (2021) — summary generated from the PubMed abstract.
- 2021
- n = 3000
BMC Pregnancy Childbirth